Z-SAVE
Allergan Pharmaceuticals International Limited
Application Filed: 2017-12-04
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87706838 |
| Registration Number | 5835466 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | N30 |
| Employee Name | MARINO, JENNIFER ELLEN |
Timeline
| 2017-12-04 | Application Filed |
| 2018-05-08 | Published for Opposition |
| 2018-12-00 | Date of First Use |
| 2019-07-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-08-13 | Status: Live/Registered |
| 2019-08-13 | Trademark Registered |
| 2019-08-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Allergan Pharmaceuticals International Limited |
| Entity Statement | private company limited by shares (prp. ltd.) |
| Address | Clonshaugh Business & Technology Park Coolock, Dublin 17 IE |
| Legal Entity Type | |
| Legal Entity State | IE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| Type Code | Type |
|---|---|
| GS0351 | Administration of a patient savings program whereby eligible patients may receive reduced out-of-pocket prescription costs, refill, dosage and administration reminders, free vitamins or supplements and live support from customer care advocates in the nature of business and administrative logistical support |
| GS0351 | Administration of a patient savings program whereby eligible patients may receive reduced out-of-pocket prescription costs, refill, dosage and administration reminders, free vitamins or supplements and live support from customer care advocates in the nature of business and administrative logistical support |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-12-07 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-12-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-02-20 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-02-25 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-02-25 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-02-25 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-03-02 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-03-02 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-03-03 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-23 | 10 CNSA P: |
| ASSIGNED TO LIE | 2018-04-01 | 11 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-04-18 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-05-08 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-05-08 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-07-03 | 15 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-12-24 | 16 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-12-24 | 17 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-12-24 | 18 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-12-26 | 19 EXRA E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-12-24 | 20 TCCA I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2019-06-17 | 21 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-06-17 | 22 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-06-20 | 23 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2019-06-17 | 24 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-06-20 | 25 EX2G S: |
| USE AMENDMENT FILED | 2019-06-17 | 26 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-06-20 | 27 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-21 | 28 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-07-05 | 29 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-07-06 | 30 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-08-13 | 31 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-05-13 | 32 ASGN I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-11-03 | 33 ASGN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-11-29 | 34 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-11-29 | 35 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-11-29 | 36 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-11-29 | 37 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-11-29 | 38 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-11-29 | 39 CHAN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-08-13 | 40 REM1 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2024-11-07 | 41 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2024-11-07 | 42 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-11-07 | 43 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-11-07 | 44 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | 2024-11-07 | 45 EWOR I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2024-11-07 | 46 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-11-07 | 47 TCCA I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 Z-SAVE 87915655 5822855 Live/Registered |
Allergan Pharmaceuticals International Limited 2018-05-10 |
 Z-SAVE 87706838 5835466 Live/Registered |
Allergan Pharmaceuticals International Limited 2017-12-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 